| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |